|
MRPL55 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.291400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.252600E-01 |
| Normal-vs-Stage2 |
2.332400E-01 |
| Normal-vs-Stage3 |
3.528400E-01 |
| Normal-vs-Stage4 |
7.000400E-01 |
| Stage1-vs-Stage2 |
1.132420E-01 |
| Stage1-vs-Stage3 |
1.900450E-01 |
| Stage1-vs-Stage4 |
7.092800E-01 |
| Stage2-vs-Stage3 |
5.972200E-01 |
| Stage2-vs-Stage4 |
1.314780E-01 |
| Stage3-vs-Stage4 |
1.716790E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.753000E-01 |
| Normal-vs-AfricanAmerican |
8.516000E-01 |
| Normal-vs-Asian |
9.796600E-01 |
| Caucasian-vs-AfricanAmerican |
9.420400E-01 |
| Caucasian-vs-Asian |
9.063600E-01 |
| AfricanAmerican-vs-Asian |
8.787800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.805000E-01 |
| Normal-vs-Female |
9.851000E-01 |
| Male-vs-Female |
1.478000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.899600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.256400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.173400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.429400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.839600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.619600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.671980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.783800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.602400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.323200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.831200E-01 |
| Classical-VS-Follicular |
1.300340E-02 |
| Classical-VS-Other |
7.564000E-01 |
| Classical-VS-Normal |
7.716400E-01 |
| Tall-VS-Follicular |
6.072100E-02 |
| Tall-VS-Other |
6.086600E-01 |
| Tall-VS-Normal |
4.479800E-01 |
| Follicular-VS-Other |
5.738600E-01 |
| Follicular-VS-Normal |
6.385900E-02 |
| Other-VS-Normal |
8.494800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.662820E-01 |
| Normal-vs-N1 |
6.392000E-01 |
| N0-vs-N1 |
5.950600E-01 |
|
|
